BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21440997)

  • 1. Adenoid cystic carcinoma of the prostate: case report on a rare entity and review of the literature.
    Ahuja A; Das P; Kumar N; Saini AK; Seth A; Ray R
    Pathol Res Pract; 2011 Jun; 207(6):391-4. PubMed ID: 21440997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asynchronous adenoid cystic carcinoma of the prostate and transitional cell carcinoma of the urinary bladder.
    Fayyad LM; Al-Jader KM; Al-Hawwari BA
    Saudi Med J; 2006 Jul; 27(7):1060-2. PubMed ID: 16830032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An unusual presentation of prostate cancer].
    Joual A; Rabii R; Aboutaeib R; el Moussaoui A; Benjelloun S
    Ann Urol (Paris); 1996; 30(5):262-3. PubMed ID: 8975593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenoid cystic carcinoma of the prostate].
    Palazzo C; Valentini M; Capuya G; Costa M
    Arch Esp Urol; 2004 Dec; 57(10):1133-5. PubMed ID: 15714854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoid cystic carcinoma of the prostate: a case report with immunohistochemical and in situ hybridization staining for prostate-specific antigen.
    Minei S; Hachiya T; Ishida H; Okada K
    Int J Urol; 2001 Aug; 8(8):S41-4. PubMed ID: 11555019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
    Huland H; Hammerer P; Henke RP; Huland E
    J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
    Bissoli E; Fandella A; La Torre E; Faggiano L; Anselmo G; Frasson F
    Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystic adenoid carcinoma of the prostate. Report of a case].
    Osorio Acosta V; Borrajero Martínez I
    Arch Esp Urol; 1997; 50(1):67-71. PubMed ID: 9182493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic endometrioid carcinoma: a case report].
    Arai G; Kawakami S; Kamata S; Ajima J; Takagi K
    Hinyokika Kiyo; 1997 Oct; 43(10):755-7. PubMed ID: 9395916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic carcinoma in a young adult: a case report].
    Yamamoto S; Senzaki A; Yamagiwa K; Tanaka T; Oda T
    Hinyokika Kiyo; 1990 May; 36(5):617-22. PubMed ID: 1698013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenoid cystic carcinoma of the prostate. A case report].
    Shindo M; Aoki S; Ikeda E
    Nihon Hinyokika Gakkai Zasshi; 1998 Jul; 89(7):670-3. PubMed ID: 9739589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced prostate cancer treated with radiotherapy and androgen deprivation.
    Kirby R
    Nat Clin Pract Urol; 2005 Jun; 2(6):304-8. PubMed ID: 16474813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long follow-up on prostate specific antigen density and prostate biopsy.
    Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
    Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
    Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
    J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.
    Birtle AJ; Freeman A; Masters JR; Payne HA; Harland SJ;
    Cancer; 2003 Dec; 98(11):2362-7. PubMed ID: 14635070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.